Literature DB >> 10376531

Expression and role of PML gene in normal adult hematopoiesis: functional interaction between PML and Rb proteins in erythropoiesis.

C Labbaye1, M Valtieri, F Grignani, R Puglisi, L Luchetti, B Masella, M Alcalay, U Testa, C Peschle.   

Abstract

The expression of the PML gene was investigated in purified early hematopoietic progenitor cells (HPCs) induced to unilineage erythroid or granulocytic differentiation. PML mRNA and protein, while barely detectable in quiescent HPCs, are consistently induced by growth factor stimulation through the erythroid or granulocytic lineage. Thereafter, PML is downmodulated in late granulocytic maturation, whereas it is sustainably expressed through the erythroid pathway. In functional studies, PML expression was inhibited by addition of antisense oligomers targeting PML mRNA (alpha-PML). Interestingly, early treatment (day 0 HPCs) with alpha-PML reduced the number of both erythroid and granulocytic colonies, whereas late treatment (day 5 culture) reduced erythroid, but not granulocytic, clonogenesis. These findings suggest that PML is required for early hematopoiesis and erythroid, but not granulocytic maturation. The pattern of PML expression in normal hematopoiesis mimics that of retinoblastoma pRb 105. Combined treatment of HPCs with alpha-PML and alpha-Rb oligomers inhibited both PML and Rb protein expression and completely blocked erythroid colony development. Furthermore, PML and pRb 105 were co-immunoprecipitated in cellular lysates derived from erythroid precursors indicating that this functional interaction may have a biochemical basis. These results suggest a key functional role of PML in early hematopoiesis and late erythropoiesis: the latter phenomenon may be related to the molecular and functional interaction of PML with pRb 105.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10376531     DOI: 10.1038/sj.onc.1202682

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  The tumor suppressor Pml regulates cell fate in the developing neocortex.

Authors:  Tarik Regad; Cristian Bellodi; Pierluigi Nicotera; Paolo Salomoni
Journal:  Nat Neurosci       Date:  2009-01-11       Impact factor: 24.884

Review 2.  PML: a tumor suppressor essential for neocortical development.

Authors:  Karisa C Schreck; Nicholas Gaiano
Journal:  Nat Neurosci       Date:  2009-02       Impact factor: 24.884

Review 3.  Cell-nonautonomous function of the retinoblastoma tumour suppressor protein: new interpretations of old phenotypes.

Authors:  David Whyatt; Frank Grosveld
Journal:  EMBO Rep       Date:  2002-02       Impact factor: 8.807

4.  Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes.

Authors:  Mark N Prichard; Elizabeth Sztul; Shannon L Daily; Amie L Perry; Samuel L Frederick; Rachel B Gill; Caroll B Hartline; Daniel N Streblow; Susan M Varnum; Richard D Smith; Earl R Kern
Journal:  J Virol       Date:  2008-03-05       Impact factor: 5.103

5.  PML-RARα interferes with erythropoiesis by repressing LMO2 in acute promyelocytic leukaemia.

Authors:  Xianwen Yang; Yun Tan; Ping Wang; Hui Zhang; Ming Zhao; Xujie Zhao; Kankan Wang
Journal:  J Cell Mol Med       Date:  2018-10-15       Impact factor: 5.310

6.  PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool.

Authors:  Wenjing Li; Brian J Ferguson; Walid T Khaled; Maxine Tevendale; John Stingl; Valeria Poli; Tina Rich; Paolo Salomoni; Christine J Watson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-04       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.